People with Alzheimer’s disease live an average of four to eight years after diagnosis, though the range is wide. Some people die within three years, while others live 20 years or more. The single biggest factor shaping that timeline is how old someone is when they’re diagnosed.
How Age at Diagnosis Shapes Survival
A Johns Hopkins analysis found that median survival drops significantly with each decade of life. Someone diagnosed at age 65 has a median survival of 8.3 years. By age 90, that number falls to 3.4 years. This isn’t just because older people are closer to the end of life in general. Alzheimer’s itself shortens the remaining lifespan dramatically: a 65-year-old with the disease loses roughly 67 percent of their expected remaining years compared to someone the same age without it. At 90, the reduction is smaller but still substantial, around 39 percent.
For people 65 and older as a group, the Alzheimer’s Association puts the average range at four to eight years after diagnosis. At age 70, having Alzheimer’s doubles the likelihood of dying before age 80 compared to people without the disease.
Early-Onset Alzheimer’s Before Age 65
When Alzheimer’s develops before age 65, the timeline becomes harder to predict. Some people live for decades after diagnosis, while others die within 10 years. Early-onset Alzheimer’s tends to progress faster than the typical form, meaning more severe symptoms arrive sooner. The speed of cognitive decline, your overall health, and any other medical conditions you have all influence how the disease unfolds. Because early-onset is relatively rare, large-scale survival data is limited, and individual experiences vary widely.
Women Live Longer After Diagnosis Than Men
Across every age group studied, women survive longer with Alzheimer’s than men. For people diagnosed between ages 75 and 84, women have a median survival of 5.1 years compared to 3.8 years for men. Among those diagnosed at 85 or older, the gap persists: 3.0 years for women versus 1.9 years for men. Overall, median survival is 3.6 years for women and 2.7 years for men. The reasons aren’t fully understood, but this pattern holds consistently.
How the Disease Progresses Over Time
Alzheimer’s moves through mild, moderate, and severe stages, though the boundaries between them blur. In the mild stage, a person can still function independently in many areas but begins forgetting recent events, misplacing things, or struggling with planning. The moderate stage is typically the longest, bringing increasing confusion, difficulty with daily tasks like dressing and bathing, personality changes, and wandering. The severe stage involves loss of the ability to communicate, walk, or swallow safely.
A striking number from the Alzheimer’s Association: a person who lives from age 70 to 80 with Alzheimer’s will spend roughly 40 percent of that decade in the severe stage. That means the final years of the disease are often the most physically demanding for both the person living with it and their caregivers.
What Actually Causes Death
Alzheimer’s itself doesn’t kill in the way a heart attack does. Instead, the disease progressively damages the brain until it can no longer control basic physical functions. In advanced stages, the ability to swallow deteriorates, which leads to food or liquid entering the lungs. This causes aspiration pneumonia, one of the most common direct causes of death. The immune system also weakens, making infections like pneumonia and the flu harder to fight off.
Other late-stage complications include falls and fractures (from loss of balance and mobility), bedsores (from being unable to move independently), and dehydration or malnutrition (from difficulty eating and drinking). These problems compound each other. A fall can lead to immobility, which leads to bedsores and infection. The combined burden of these complications is what ultimately proves fatal. One in three older Americans dies with Alzheimer’s or another form of dementia, making it the fifth-leading cause of death among people 65 and older. Deaths from Alzheimer’s have increased 134 percent since 2000.
Signs the Final Stage Has Arrived
Families often want to know when the end is approaching. Clinicians use a staging tool called the FAST scale to assess how far the disease has progressed. Stage 7 on this scale is the threshold associated with a life expectancy of roughly six months or less, and it’s the point at which hospice care becomes an option under Medicare.
At this stage, a person’s speech is limited to five words or fewer per day, or they may lose all intelligible language entirely. They can no longer walk independently, sit up without support, or eventually hold their head up. The ability to smile disappears. When these functional losses are combined with complications like recurrent infections, difficulty swallowing, or significant weight loss, the prognosis is typically six months or less. Recognizing these signs can help families make decisions about comfort-focused care.
Whether New Treatments Change the Timeline
Two newer medications that target the underlying brain changes in Alzheimer’s have drawn attention for their potential to slow progression. In clinical trials, one of these drugs delayed progression to the next disease stage by about 18 months compared to untreated patients (reaching the same level of decline at 60 months instead of 42). The other delayed progression to severe dementia by roughly 5 to 26 months, depending on how fast the disease was already advancing at the start of treatment.
These are meaningful delays in progression, but they come with important caveats. The data beyond the initial 18-month trial periods relies on projections and unproven assumptions. Neither drug has been shown to extend overall survival in completed trials. They also only work in the early stages of the disease, so they’re not an option for someone already in moderate or severe Alzheimer’s. For now, the core survival statistics remain largely unchanged.